Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

- Siva, Shankar, Bressel, Mathias, Lin, Charles, Raman, Avi, Hardcastle, Nicholas, Hofman, Michael S., De Abreu Lourenco, Richard, Shaw, Mark, Mancuso, Pascal, Moon, Daniel, Wong, Lih-Ming, Lawrentschuk, Nathan, Sidhom, Mark, Wood, S, Brook, NR, Kron, T, Martin, Jarad, Pryor, D, FASTRACK II Investigator Group,, Sridharan, Swetha, Vanneste, Ben G. L., Davey, Ryan, Montgomery, Rebecca, Ruben, Jeremy, Foroudi, Farshad, Higgs, Braden

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

- Hofman, Michael S., Lawrentschuk, Nathan, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Link, Emma, Marusic, Petra, Francis, Roslyn J., Matera, A, Herschtal, A, Iravani, A, Hicks, RJ, Williams, S, Murphy, DG, Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave

Quantifying the effect of location matching on accuracy of multiparametric magnetic resonance imaging prior to prostate biopsy—A multicentre study

- Gavin, Dominic James, Kam, Jonathan, Skinner, Sarah, Brennan, Janelle, Wong, Lih-Ming, Krelle, Matthew, Louie-Johnsun, Mark, Sutherland, Tom, Koschel, Samantha, Jenkins, Mark, Yuminaga, Yuigi, Kim, Raymond, Aluwihare, Kushlan

Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study

- Kam, Jonathan, Yuminaga, Yuigi, Louie-Johnsun, Mark, Krelle, Matthew, Gavin, Dominic, Koschel, Samantha, Aluwihare, Kushlan, Sutherland, Tom, Skinner, Sarah, Brennan, Janelle, Wong, Lih-Ming